CGT Global News
Featured Post
Charlotte Ivancic brings more than 18 years of experience on Capitol Hill, where she played a key role in shaping healthcare legislation and advising senior leadership in both the U.S. Senate and House of Representatives. Her…
Leukopak vs PBMC vs Whole Blood: What’s the Difference and Which One Do You Need? Cell therapy, immunology, and translational research programs all rely on high quality human blood derived materials. But one of the most…
Introduction T cell activation is a foundational step in cell and gene therapy workflows, particularly in CAR T and other adoptive cell therapies. While much attention is placed on genetic engineering and manufacturing scale, activation is…
Cell and gene therapy companies rely on several critical pieces of infrastructure to move therapies from development to clinical trials and ultimately to patient treatment. These include reliable sources of GMP compatible starting material,…